Literature DB >> 1394058

Neuropsychologic impairment in adult bone marrow transplant candidates.

M A Andrykowski1, F A Schmitt, M E Gregg, M J Brady, D G Lamb, P J Henslee-Downey.   

Abstract

BACKGROUND: Long-term cognitive impairment has been reported in adult bone marrow transplant (BMT) recipients. However, the degree to which such impairment is attributable to the procedure or is a condition existing before BMT is not known.
METHODS: The presence, nature, and correlates of neuropsychologic impairment were investigated in 55 adult BMT candidates, all of whom had a malignant condition. Impairment was assessed using a screening battery of standardized neuropsychologic tests.
RESULTS: Results indicated that: (1) neuropsychologic performance was associated with specific disease and treatment risk factors, in particular a history of cranial radiation or central nervous system disease treated with intrathecal chemotherapy; (2) performance on tests reflecting memory or higher cognitive processing was more likely to be impaired; and (3) the risk of impairment increased as the number of disease and treatment risk factors for cognitive impairment in the patient increased.
CONCLUSIONS: It was concluded that neuropsychologic impairment occurs in a significant minority of adult patients before BMT. Research is necessary to determine the extent to which such impairment significantly compromises patients' abilities to: (1) make decisions regarding undergoing BMT or participating in research protocols and (2) understand and execute self-care behaviors after BMT. More broadly, greater attention should be devoted to investigating the presence of long-term neuropsychologic impairment in adult patients with cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1394058     DOI: 10.1002/1097-0142(19921101)70:9<2288::aid-cncr2820700913>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation.

Authors:  Heather S L Jim; Brent Small; Sheri Hartman; Jamie Franzen; Shannon Millay; Kristin Phillips; Paul B Jacobsen; Margaret Booth-Jones; Joseph Pidala
Journal:  Cancer       Date:  2011-12-02       Impact factor: 6.860

2.  Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.

Authors:  Kristine A Donovan; Brent J Small; Michael A Andrykowski; Frederick A Schmitt; Pamela Munster; Paul B Jacobsen
Journal:  Cancer       Date:  2005-12-01       Impact factor: 6.860

3.  A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients.

Authors:  D D Correa; J C Root; R Baser; D Moore; K K Peck; E Lis; T B Shore; H T Thaler; A Jakubowski; N Relkin
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

4.  Prospective assessment of white matter integrity in adult stem cell transplant recipients.

Authors:  D D Correa; Y Wang; J D West; K K Peck; J C Root; R E Baser; H T Thaler; T B Shore; A Jakubowski; A J Saykin; N Relkin
Journal:  Brain Imaging Behav       Date:  2016-06       Impact factor: 3.978

5.  Cognitive functioning in breast cancer survivors: a controlled comparison.

Authors:  Heather S L Jim; Kristine A Donovan; Brent J Small; Michael A Andrykowski; Pamela N Munster; Paul B Jacobsen
Journal:  Cancer       Date:  2009-04-15       Impact factor: 6.860

Review 6.  Neuropsychological sequelae of non-central nervous system cancer and cancer therapy.

Authors:  Jeffrey S Wefel; Mariana E Witgert; Christina A Meyers
Journal:  Neuropsychol Rev       Date:  2008-04-16       Impact factor: 7.444

7.  Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant.

Authors:  Desiree Jones; Elisabeth G Vichaya; Xin Shelley Wang; Mary H Sailors; Charles S Cleeland; Jeffrey S Wefel
Journal:  Cancer       Date:  2013-09-16       Impact factor: 6.860

8.  Predictors of neuropsychological change in patients with chronic myelogenous leukemia and myelodysplastic syndrome.

Authors:  Mary-Ellen Meadows; Grace Chang; Jennifer A Jones; Joseph R Antin; E John Orav
Journal:  Arch Clin Neuropsychol       Date:  2013-02-07       Impact factor: 2.813

9.  Mental status changes after hematopoietic stem cell transplantation.

Authors:  Grace Chang; Mary-Ellen Meadows; E John Orav; Joseph H Antin
Journal:  Cancer       Date:  2009-10-01       Impact factor: 6.860

10.  Impact of delirium on distress, health-related quality of life, and cognition 6 months and 1 year after hematopoietic cell transplant.

Authors:  James R Basinski; Catherine M Alfano; Wayne J Katon; Karen L Syrjala; Jesse R Fann
Journal:  Biol Blood Marrow Transplant       Date:  2010-01-25       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.